Leave Your Message

Indwara ya Lymphoblastique ikaze (T-BYOSE) -03

Mwihangane: Huang XX

Uburinganire: Umugabo

Imyaka: Imyaka 42

Ubwenegihugu: Igishinwa

Gusuzuma: Indwara ya Lymphoblastique ikaze (T-BYOSE)

    Ibiranga urubanza:

    - Gusuzuma: Indwara ya T-selile lymphoblastique leukemia

    - Gutangira n'ibimenyetso: Mata 2020, byerekanwe no kuzunguruka, umunaniro, hamwe no kuva amaraso. Yasuzumwe na T-selile lymphoblastique leukemia ikoresheje igufwa ryamagufwa MICM.

    .

    - Ku ya 19 Nyakanga 2020: Yakiriye allogeneic hematopoietic stem selile transplantation yatanzwe numuterankunga wumugore (HLA 5/10 Umuterankunga A). Muri gahunda harimo gushyiramo imirasire yumubiri wose (TBI), cyclophosphamide (CY), na etoposide (VP-16). Utugingo ngengabuzima twa periferique twashyizwemo ku ya 24 Nyakanga, hamwe na granulocyte yakira ku munsi +10 hamwe na platel ku munsi +13. Gukurikirana kwa muganga buri gihe nyuma.

    - 25 Gashyantare 2021: Gusubiramo amagufwa yongeye kugaragara mugihe cyo gukurikirana.

    - Umuti: Gutangira kuvura umunwa thalidomide.

    - 8 Werurwe: Yinjiye mu bitaro byacu.

    - Amagufwa ya Morphology: 61.5% yaturika.

    - Amaraso ya Periferique Itondekanya: guturika 15%.

    - Immunophenotyping: 35,25% selile zigaragaza CD99, CD5, CD3dim, CD8dim, CD7, cCD3, CD2dim, HLA-ABC, cbcl-2, CD81, CD38, byerekana lymphocytes T idakuze.

    - Isesengura rya Chromosome: 46, XX [9].

    - Leukemia Fusion Gene: SIL-TAL1 fusion gene nziza; gupima ingano: SIL-TA.

    - Guhinduranya Amaraso Kumubiri: Bibi.

    - Isesengura rya Chimerism (nyuma ya HSCT): Ingirabuzimafatizo zikomoka ku baterankunga zingana na 45,78%.

    - Tariki ya 11 Werurwe: Ikusanyirizo rya autologique peripheral maraso lymphocytes kumico ya CD7-CART.

    - Umuti: VILP (VDS 4mg, IDA 10mg, L-asparaginase 10,000 IU qd x iminsi 4, Dex 9mg q12h x iminsi 9) gahunda ihujwe na thalidomide kugirango igenzure ikibyimba.

    - 19 Werurwe: FC regimen chimiotherapie (ibicurane 50mg x iminsi 3, CTX 0.4gx iminsi 3).

    - 24 Werurwe (pre-infusion): Amagufwa ya marrow morphologie yerekanaga hyperplasia yo mu cyiciro cya V, hamwe na 22%.

    - Amagufa ya marrow Flow Cytometrie: 29.21% selile (ya selile nucleated selile) yerekana CD3, CD5, CD7, CD99, igaragaza igice cCD3, byerekana selile T idakuze.

    - Umubare SIL-TAL1 Fusion Gene: 1.913%.

    25dho

    Umuti:
    - 26 Werurwe: Kwinjiza CD7-CART selile (5 * 10 ^ 5 / kg)
    - CAR-T Ingaruka Zifitanye isano: CRS icyiciro cya 1 (umuriro), nta neurotoxicity
    - Tariki ya 12 Mata (Umunsi wa 17): Gukurikirana byerekanaga morfologiya yo mu magufa mu gukira, nta selile zidakuze zagaragajwe na cytometrike, na SIL-TAL1 (STIL-SCL) ingano ya gene ya 0

    26i6g

    ibisobanuro2

    Fill out my online form.